Author: OurCrowd

[EquipmentShare in BusinessWire] EquipmentShare celebrates grand opening of new branch in Oregon — part of a statewide expansion exceeding $185 million

Oct 23, 2025 |

REDMOND, Ore.–(BUSINESS WIRE)–EquipmentShare, a leading technology-driven equipment rental and solutions provider in the United States, today opened its new branch in Redmond, Oregon, marking an important milestone in a statewide expansion. The company’s $185 million investment in Oregon is expected to create up to 120 new jobs and bring its total footprint in the state to 10 locations. State and local officials joined EquipmentShare leadership for a ribbon-cutting ceremony at the new facility at 2475 NW Canal Blvd. Read...

Read More

[Clinch in PR Newswire] Clinch named First Third-Party Ad Serving Solution to Serve Ads to Amazon Custom Audiences, Utilizing a S2S (Server-to-Server) Integration

Oct 23, 2025 |

NEW YORK, Oct. 23, 2025 /PRNewswire/ — Clinch, the Agentic AI platform for omnichannel advertising, today announced an expanded collaboration with Amazon Ads, becoming the first third-party ad serving solution to serve ads to Amazon Custom Audiences, a functionality reserved for creatives served directly by Amazon. Amazon Custom Audiences are custom-built segments that can help brands reach and re-engage with shoppers directly via Amazon DSP. Read more...

Read More

[Alloy Therapeutics in BusinessWire] Alloy Therapeutics announces acquisition of Spannerwerks, a leading provider of drug development consulting services

Oct 23, 2025 |

BOSTON–(BUSINESS WIRE)–Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced the acquisition of Spannerwerks, LLC, a Seattle-based professional services firm that guides biopharmaceutical companies on the development and launch of new products. Read more...

Read More

[OncoHost in PR Newswire] OncoHost receives New York StatelLaboratory permit, expanding availability of PROphetNSCLC® precision oncology test

Oct 22, 2025 |

BINYAMINA, Israel and CARY, N.C., Oct. 22, 2025 /PRNewswire/ — OncoHost, a technology company transforming the approach to precision medicine through plasma proteomics and AI, today announced that it has received a laboratory permit from the New York State Department of Health Wadsworth Center. This permit enables the company to offer its PROphetNSCLC® test to physicians and patients across New York State, marking a key milestone in OncoHost’s U.S. expansion. Read more...

Read More